Calming and Sleeping in Portugal

Calming and Sleeping in Portugal

  • April 2015
  • 22 pages
  • Euromonitor International
Report ID: 190162
Calming and sleeping increased by 2% in current value terms in 2014, reaching €6 million. This was a slightly better performance than the CAGR registered in the review period as a whole. Whilst Portugal emerged from recession during the second half of the previous year, consumer sentiment remained low in 2014. Low consumer confidence in Portugal, coupled with a declining but still high unemployment rate, continued to drive up sales of such products, at a time when sales of most OTC medicines...

Euromonitor International's Calming and Sleeping in Portugal report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Data Coverage:

market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

* Get a detailed picture of the Calming and Sleeping market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

CALMING AND SLEEPING IN PORTUGAL
Euromonitor International
April 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Calming and Sleeping: Value 2009-2014
Table 2 Sales of Calming and Sleeping: % Value Growth 2009-2014
Table 3 NBO Company Shares of Calming and Sleeping: % Value 2010-2014
Table 4 LBN Brand Shares of Calming and Sleeping: % Value 2011-2014
Table 5 Forecast Sales of Calming and Sleeping: Value 2014-2019
Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2014-2019
Executive Summary
Consumer Health Shows Signs of Slow Recovery
Demographic Changes Shake Up Consumer Health
Voltaren 12.5 Is the Most Successful Brand From Novartis in 2014
Parapharmacies/drugstores Gains Ground Against Chemists/pharmacies
Growth in Consumer Health Set To Be Slow Over the Forecast Period
Key Trends and Developments
the Portuguese Economic Environment Continues To Undermine Consumer Health, But Prospects Improve
Demographic Shifts Play A Key Role in the Demand for Consumer Health Products
the Ongoing Evolution of Portugal's System for the Distribution of OTC Products
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 8 Life Expectancy at Birth 2009-2014
Market Data
Table 9 Sales of Consumer Health by Category: Value 2009-2014
Table 10 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 11 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 12 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2009-2014
Table 14 Distribution of Consumer Health by Format: % Value 2009-2014
Table 15 Distribution of Consumer Health by Format and Category: % Value 2014
Table 16 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches 2012-2014
Definitions
Sources
Summary 2 Research Sources












Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.

Country=Portugal Industry=OTC ParentIndustry=Pharmaceutical Date=201504 Topic=MarketReport Publisher=EuromonitorInternational Price=1000